24 Van Karnebeek CD, Naeff MS, Mulder BJ, Hennekam RC, Offringa M Natural history of cardiovascular manifestations in marfan syndrome Arch Dis Child 2001;84(2):129–137 25 Pepin M, Schwarze U, Superti-Furga A, Byers PH Clinical and genetic features of Ehlersdanlos syndrome type IV, the vascular type N Engl J Med 2000;342(10):673–680 26 Grau JB, Pirelli L, Yu P-J, Galloway AC, Ostrer H The genetics of mitral valve prolapse Clin Genet 2007;72(4):288–295 27 Durst R, Sauls K, Peal DS, et al Mutations in DCHS1 cause mitral valve prolapse Nature 2015;525(7567):109–113 28 Chauvaud SM, Milhaileanu SA, Gaer JAR, Carpentier AC Surgical treatment of congenital mitral valvar insuffciency: “the hôpital Broussais” experience Cardiol Young 1997;7(1):5–14 29 Chauvaud SM, Milhaileanu SA, Gaer JAR, Carpentier AC Surgical treatment of congenital mitral valvar stenosis: “the hôpital Broussais” experience Cardiol Young 1997;7(1):15–21 30 Becker AE Valve pathology in the paediatric age group Churchill Livingstone: Edinburgh; 1983:345–360 Anderson RH, Macartney FJ, Shinebourne EA, Tynan M Paediatric Cardiology Vol 5 31 Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L Congenital heart disease in the general population: changing prevalence and age distribution Circulation 2007;115(2):163–172 32 Yakub MA, Krishna Moorthy PS, Sivalingam S, Dillon J, Kong PK Contemporary long-term outcomes of an aggressive approach to mitral valve repair in children: is it effective and durable for both congenital and acquired mitral valve lesions Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg 2016;49(2):553– 560 [discussion 560] 33 Caldarone CA, Raghuveer G, Hills CB, et al Long-term survival after mitral valve replacement in children aged